首頁 > 市場調查報告書 > 醫療設備

齒科設備

牙科感染疾病治療市場規模、佔有率和成長分析（按治療類型、感染疾病類型、最終用戶和地區）：產業預測（2025-2032 年）

市場調查報告書

商品編碼

1796120

牙科感染疾病治療市場規模、佔有率和成長分析（按治療類型、感染疾病類型、最終用戶和地區）：產業預測（2025-2032 年）

Dental Infection Treatment Market Size, Share, and Growth Analysis, By Treatment Type (Antibiotics, Antifungals), By Infection Type (Periodontal Infections, Endodontic Infections), By End-Users, By Region - Industry Forecast 2025-2032

出版日期: 2025年08月13日 | 出版商:

SkyQuest | 英文 184 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計 2023 年全球牙科感染疾病治療市場規模將達到 124.8 億美元，2024 年將成長至 136.4 億美元，2032 年將成長至 277.8 億美元，預測期內（2025-2032 年）的複合年成長率為 9.30%。

全球牙科感染疾病治療市場正在經歷顯著成長，主要原因是牙周炎、齲齒和牙髓感染等牙科疾病的盛行率不斷上升。口腔衛生意識的提高和人口老化導致更容易出現牙科問題，這推動了對有效治療方案的需求。診斷和治療方法的技術進步，包括微創手術和創新抗菌策略，進一步推動了這一成長。然而，挑戰依然存在，包括先進治療的高成本、發展中地區治療的可及性有限以及牙科保險覆蓋不足。此外，病原體抗生素抗藥性的不斷增加使得治療技術必須不斷創新。人工智慧和物聯網在患者診斷和監測中的整合，為改善早期檢測和加強該市場的患者護理提供了機會。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業的市場定位（2024年）
主要企業採取的策略
近期市場趨勢
主要企業市場佔有率（2024年）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分析市場佔有率
- 收益同比對比（2022-2024 年）

主要企業簡介

帕特森牙科供應公司（美國）
強生公司（美國）
輝瑞公司（美國）
克爾公司（美國）
百時美施貴寶（美國）
Septodont Healthcare India Pvt. Ltd.（印度）
亨利·沙因公司（美國）
Ultradent Products Inc.（美國）
Endo Pharmaceuticals（美國）
泰姬製藥有限公司（印度）
第一三共（日本）
拜耳醫藥保健（德國）
Young Innovations, Inc.（美國）
3M（美國）
A-dec Inc.（美國）
Dentsply Sirona公司（美國）
COLTENE集團（瑞士）
Getinge AB（瑞典）
GC America Inc.（美國）

結論和建議

簡介目錄

Product Code: SQMIG35D2342

Global Dental Infection Treatment Market size was valued at USD 12.48 Billion in 2023 poised to grow between USD 13.64 Billion in 2024 to USD 27.78 Billion by 2032, growing at a CAGR of 9.30% in the forecast period (2025-2032).

The global dental infection treatment market is experiencing notable growth driven primarily by the increasing prevalence of dental diseases such as periodontitis, caries, and endodontic infections. Heightened awareness of oral hygiene, along with an aging demographic prone to dental issues, fuels demand for effective treatment options. Technological advancements in diagnostics and treatment methodologies, including minimally invasive procedures and innovative antimicrobial strategies, further bolster this growth. However, challenges persist due to the high costs associated with advanced treatments, limited accessibility in developing regions, and inadequate dental insurance coverage. Additionally, rising antimicrobial resistance among pathogens necessitates ongoing innovations in treatment. The integration of AI and IoT in patient diagnostics and monitoring presents opportunities for improving early detection and enhancing patient care in this market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dental Infection Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dental Infection Treatment Market Segments Analysis

The global dental infection treatment market is segmented based on treatment type, infection type, end-user, and region. In terms of treatment type, the market is divided into antibiotics, antifungals, antivirals, pain management, surgical procedures, and topical medications. Based on infection type, the market is bifurcated into periodontal infections, endodontic infections, caries-related infections, pericoronitis, and oral candidiasis. Based on end-user, the market is grouped into dental clinics, hospitals, ambulatory surgical centres, and research & academic institutions. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Driver of the Global Dental Infection Treatment Market

One key market driver for the global dental infection treatment market is the rising prevalence of dental diseases and infections, largely attributed to poor oral hygiene, unhealthy dietary habits, and a lack of awareness about dental care. As more individuals experience conditions such as periodontitis, dental abscesses, and endodontic infections, the demand for effective treatment options increases. This growing incidence of dental infections not only necessitates advancements in treatment technologies and pharmaceuticals but also fosters a greater emphasis on preventive care and public awareness campaigns, thus propelling the overall market for dental infection treatment solutions worldwide.

Restraints in the Global Dental Infection Treatment Market

One significant market restraint for the global dental infection treatment market is the rising prevalence of antibiotic resistance. As more bacteria develop resistance to commonly used antibiotics, the effectiveness of traditional treatments is compromised, leading to challenges in managing dental infections. This growing issue not only affects patient outcomes but also complicates treatment protocols for dental professionals. Additionally, the increasing awareness and caution among healthcare providers regarding the over-prescription of antibiotics may limit the adoption of necessary medical interventions. Consequently, the need for alternative treatment options and effective infection control measures becomes paramount, impacting the market's growth potential.

Market Trends of the Global Dental Infection Treatment Market

The global dental infection treatment market is experiencing a significant transformation driven by the integration of digital dentistry and AI-powered diagnostic solutions. These advancements facilitate enhanced imaging capabilities and streamline diagnostic processes, enabling clinicians to identify and address infections more promptly and effectively. As a result, personalized treatment plans are emerging, tailored to individual patient needs, which improves both diagnostic accuracy and overall health outcomes. Furthermore, the adoption of these innovative technologies enhances clinical workflows, fosters greater efficiency in dental practices, and sets the stage for ongoing innovations, underscoring a dynamic shift in how dental infections are diagnosed and treated worldwide.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Case Studies
Customer Buying Behavior Analysis

Global Dental Infection Treatment Market Size by Treatment Type & CAGR (2025-2032)

Market Overview
Antibiotics
Antifungals
Antivirals
Pain Management
Surgical Procedures (Root Canal, Extraction)
Topical Medications

Global Dental Infection Treatment Market Size by Infection Type & CAGR (2025-2032)

Market Overview
Periodontal Infections (Gingivitis, Periodontitis)
Endodontic Infections (Pulpitis, Abscesses)
Caries-Related Infections
Pericoronitis
Oral Candidiasis

Global Dental Infection Treatment Market Size by End Users & CAGR (2025-2032)

Market Overview
Dental Clinics
Hospitals
Ambulatory Surgical Centres
Research & Academic Institutions

Global Dental Infection Treatment Market Size & CAGR (2025-2032)

North America (Treatment Type, Infection Type, End Users)
- US
- Canada
Europe (Treatment Type, Infection Type, End Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Treatment Type, Infection Type, End Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Treatment Type, Infection Type, End Users)
- Brazil
- Rest of Latin America
Middle East & Africa (Treatment Type, Infection Type, End Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Patterson Dental Supply, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kerr Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Septodont Healthcare India Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Henry Schein, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ultradent Products Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endo Pharmaceuticals (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Taj Pharmaceuticals Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Daiichi Sankyo (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer HealthCare (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Young Innovations, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
A-dec Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dentsply Sirona Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
COLTENE Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GC America Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments